Advertisement

Is Reduced Cell Swelling a Plausible End-Effector of Ischemic Preconditioning Protection?

Part of the Progress in Experimental Cardiology book series (PREC, volume 6)

Summary

Ischemic preconditioning (IPC) is an endogenous mode of cardioprotection that is induced by a cycle of brief ischemia and reperfusion. Ischemic preconditioning reduces infarct size in intact animal models, reduces reoxygenation necrosis and enzyme release in perfused hearts, delays the onset of osmotic fragility in isolated cardiomyocyte models and attenuates necrosis and apoptosis in cultured cardiomyocyte models. A variety of mechanisms have been proposed to mediate the cardioprotection provided by ischemic preconditioning. These include: 1) Activation of PKC and MAPK pathways; 2) Reductions in ischemic ATP depletion, electrolyte changes, or free radical generation; 3) Production of nitric oxide; and 4) Opening of the mitochondrial KATP channel. However, there is currently no clear consensus on the end-effector mechanism(s) responsible for the cardioprotection provided by ischemic preconditioning. A recent report indicates that ischemic preconditioning enhances cell volume regulation and reduces the swelling of isolated cardiomyocytes during simulated ischemia (24). Evidence relevant to the novel hypothesis that reduced cellular swelling may be an end-effector of preconditioning protection is briefly reviewed below.

Key words

Ischemic preconditioning Cell volume regulation Mitochondria Isolated Cardiomyocytes Ischemia 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ganote CE, Humphrey SM. 1985. Effects of anoxic or oxygenated reperfusion in globally ischemic, isovolumic, perfused rat hearts. Am J Pathol 120:129–145.PubMedGoogle Scholar
  2. 2.
    Ganote CE, Vander Heide RS. 1988. Irreversible injury of isolated adult rat myocytes: Osmotic fragility during metabolic inhibition. Am J Path 132:212–222.PubMedGoogle Scholar
  3. 3.
    Jennings RB, Reimer KA, Steenbergen C. 1986. Editorial. Myocardial ischemia revisited. The osmolar load, membrane damage and reperfusion. J Mol Cell Cardiol 18:769–680.PubMedCrossRefGoogle Scholar
  4. 4.
    Tranum-Jensen J, Janse MJ, Fiolet JWT, Krieger JG, D’Alnoncourt CN, Durrer D. 1981. Tissue osmolality, cell swelling, and reperfusion in acute regional myocardial ischemia in the isolated porcine heart. Circ Res 49:364–381.PubMedCrossRefGoogle Scholar
  5. 5.
    Kloner RA, Ganote CE, Whalen DA, Jennings RB. 1974. Effects of a transient period of ischemia on myocardial cells. II. Fine structure during the first few minutes of reflow. Am J Pathol 74:399–422.PubMedGoogle Scholar
  6. 6.
    Ganote CE, Worstell J, Kaltenbach JP. 1976. Oxygen-induced enzyme release after irreversible myocardial injury: Effects of cyanide in perfused rat hearts. Am J Path 84:327–350.PubMedGoogle Scholar
  7. 7.
    Ganote CE, Kaltenbach JP. 1979. Oxygen-induced enzyme release: Early events and proposed mechanism. J Mol Cell Cardiol 11:389–406.PubMedCrossRefGoogle Scholar
  8. 8.
    Piper HM, Schwartz P, Spahr R, Hutter JF, Spieckerman PG. 1987. Anoxic injury of adult cardiac myocytes. Basic Res in Cardiol 80:37–42.Google Scholar
  9. 9.
    Piper HM, Spahr R, Huttner JF, Spieckermann PG 1985. The calcium and the oxygen paradox: Non-existent on the cellular level. Basic Res Cardiol 80:159–163.PubMedGoogle Scholar
  10. 10.
    Siegmund B, Klietz T, Schwartz P, Piper HM. 1991. Temporary contractile blockade prevents hypercontracture in anoxic-reoxygenated cardiomyocytes. Am J Physiol 260 (Heart Circ Physiol 29): H426–H435.PubMedGoogle Scholar
  11. 11.
    Ganote CE, Vander Heide RS, Importance of mechanical factors in ischemic and reperfusion injury, in Pathophysiology of severe ischemic myocardial injury, e.H. Piper, Editor. 1990, Kluwer Academic Publishers: Dordrecht, p. 337–355.CrossRefGoogle Scholar
  12. 12.
    Ganote CE, Sims M, Safavi S. 1982. Effects of dimethylsulfoxide (DMSO) on the oxygen paradox in perfused rat hearts. Am J Pathol 104:270–276.Google Scholar
  13. 13.
    Armstrong SC, Ganote CE. 1991. Effects of 2,3-butanedione monoxime (BDM) on contracture and injury of isolated rat myocytes following metabolic inhibition and ischemia. J Mol Cell Cardiol 23:1001–1014.PubMedCrossRefGoogle Scholar
  14. 14.
    Ganote CE, Iannotti JP, Kaltenbach JP. 1978. Effects of hyperosmolar solutions of polyethylene glycol, dextran and mannitol on enzyme release from perfused rat hearts. J Mol Cell Cardiol 10:725–737.PubMedCrossRefGoogle Scholar
  15. 15.
    Jennings RB, Ganote CE, Reimer KA. 1975. Ischemic tissue injury. Am J Pathol 81:179–198.PubMedGoogle Scholar
  16. 16.
    Ganote CE, Vander Heide RS. 1987. Cytoskeletal lesions in anoxic myocardial injury: A conventional and high voltage electron microscopic and immunofluorescence study. Am J Pathol 129:327–344.PubMedGoogle Scholar
  17. 17.
    Sage MD, Jennings RB. 1988. Cytoskeletal injury and subsarcolemmal bleb formation in dog heart during in vitro total ischemia. Am J Pathol 133:327–337.PubMedGoogle Scholar
  18. 18.
    Armstrong SC, Ganote CE. 1992. Flow cytometric analysis of isolated adult cardiomyocytes: Vinculin and tubulin fluorescence during metabolic inhibition and ischemia. J Mol Cell Cardiol 24:149–162.PubMedCrossRefGoogle Scholar
  19. 19.
    Armstrong SC, Delacey M, Ganote CE. 1999. Phosphorylation state of hsp27 and p38 MAPK during preconditioning and protein phosphatase inhibitor protection of rabbit cardiomyocytes. J Mol Cell Cardiol 31:555–567.PubMedCrossRefGoogle Scholar
  20. 20.
    Armstrong SC, Shivell LC, Ganote CE. 2000. Differential translocation or phosphorylation of alpha B crystallin cannot be detected in ischemically preconditioned rabbit cardiomyocytes. J Mol Cell Cardiol 32:1301–1314.PubMedCrossRefGoogle Scholar
  21. 21.
    Armstrong S, Latham C, Shivell L, Ganote C. 2001. Ischemic loss of sarcolemmal dystrophin and spectrin: Correlation with myocardial injury. J Mol Cell Cardiol 33:1165–1179.PubMedCrossRefGoogle Scholar
  22. 22.
    Diaz RJ, Losito VA, Mao GD, Ford MK, Backxx PH, Wilson GL. 1999. Chloride channel inhibition blocks the protection of ischemic preconditioning and hypo-osmotic stress in rabbit ventricular myocardium. Circ Res 84:763–775.PubMedCrossRefGoogle Scholar
  23. 23.
    Diaz R, Battish M, Hinek A, Wilson G. 2001. Regulatory volume decrease requires CI- channel activation in rabbit ventricular myocytes. (Abst). J. Mol Cell Cardiol 33:A28.CrossRefGoogle Scholar
  24. 24.
    Diaz R, Armstrong SC, Ganote CE, Wilson GJ. Submitted. Enhanced cell volume regulation: A key protective mechanism of ischmeic preconditioning in rabbit ventricular myocytes. J Mol Cell Cardiol (under revision)Google Scholar
  25. 25.
    Roos KP. 1986. Length, width, and volume changes in osmoticaly stressed myocytes. Am J Physiol (Heart Circ Physiol 20): H 1373–1378.Google Scholar
  26. 26.
    Severs NJ, Slade AM, Powell T, Twist VW, Jones GE. 1985. Morphometric analysis of the isolated calcium-tolerant cardiac myocyte. Cell Tissue Res 240:159–168.PubMedCrossRefGoogle Scholar
  27. 27.
    Bernardi P. 1992. Modulation of the mitochondrial permeability transition pore by the proton electrochemical gradient. Evidence that the pore can be opened by membrane depolarization. J Biol Chem 267:8834–8839.PubMedGoogle Scholar
  28. 28.
    Di Lisa F, Menabo R, Canton M, Barile M, Bernardi P. 2001. Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J Biol Chem 276:2571–2575.PubMedCrossRefGoogle Scholar
  29. 29.
    Bernardi P, Broekmeier K, Pfeiffer D. 1994. Recent progress on the regulation of the mitochondrial permeability transition pore; a cyclosporin-sensitive pore in the inner mitochondrial membrane. J. Bioenerg. Biomembr 26:509–517.PubMedCrossRefGoogle Scholar
  30. 30.
    Davidson A, Halestrap A. 1990. Partial inhibition by cyclosporin A of the swelling of liver mitochondria in vivo and in vitro induced by sub-micromolar [Ca++], but not by butyrate: Evidence for two mechanisms. Biochem J. 268:147–152.PubMedGoogle Scholar
  31. 31.
    Petronilli V, Miotto G, Canton M, Brini M, Colonna R, Bernardi P, Di Lisa F. 1999. Transient and long-lasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fluorescence. Biophys J 76:725–734.PubMedCrossRefGoogle Scholar
  32. 32.
    Allen SP, Darley-Usmar VM, McCormack JG, Stone D. 1993. Changes in mitochondrial matrix free calcium in perfused rat hearts subjected to hypoxia-reoxygenation. J Mol Cell Cardiol 25:949–958.PubMedCrossRefGoogle Scholar
  33. 33.
    Gao W, Pu Y, Luo KQ, Chang DC. 2001. Temporal relationship between cytochrome c release and mitochondrial swelling during UV-induced apoptosis in living HeLa cells. J. Cell Science 114:2855–2862.PubMedGoogle Scholar
  34. 34.
    Xu M, Wang Y, Ayub A, Ashraf M . 2001. Mitochondrial KATP channel activation reduces anoxic injury by restoring mitochondrial membrane potential. Am J Physiol (Heart Circ Physiol) 281:H1295–H1303.Google Scholar
  35. 35.
    Tani M, Neely JR. 1990. Na+ accumulation increases Ca2+ overload and impairs function in anoxic rat heart. J Mol Cell Cardiol 22:57–72.PubMedCrossRefGoogle Scholar
  36. 36.
    Steenbergen C, Perlman ME, London RE, Murphy E. 1993. Mechanism of preconditioning: Ionic alterations. Circ Res 72:112–125.PubMedCrossRefGoogle Scholar
  37. 37.
    Garlid KD. 2000. Opening mitochondrial KATP in the heart—what happens, and what does not happen. Basic Res Cardiol 95:275–279.PubMedCrossRefGoogle Scholar
  38. 38.
    Grover GJ, Garlid KD. 2000. ATP-sensitive potassium channels: A review of their cardioprotective pharmacology. J Mol Cell Cardiol 32:677–695.PubMedCrossRefGoogle Scholar
  39. 39.
    Pain T, Yang X, Critz S, Yue Y, Nakano A, Liu G, Heusch G, Cohen M, Downey J. 2000. Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals. Circ Res 87:460–466.PubMedCrossRefGoogle Scholar
  40. 40.
    Garlid KD, Beavis AD. 1986. Evidence for the existence of an inner membrane anion channel in mitochondria. Biochem BiophysActa 853:187–204.Google Scholar
  41. 41.
    Garlid KD. 1996. Cation transport in mitochondria—the potassium cycle. Biochim Biophys Acta 1275:123–126.PubMedCrossRefGoogle Scholar
  42. 42.
    Garcia-Dorado D, Gonzalez MA, Barrabes JA, Ruiz-Meana M, Solares J, Lindon R-M, Blanco J, Puigfel Y, Piper HM, Soler-Soler J. 1997. Prevention of ischemic rigor contracture during coronary occlusion by inhibition of Na+/H+ exchange. Cardiovas Res 35:80–89.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  1. 1.Veteran Affairs Medical Center and Department of Pathology, James H. Quillen College of MedicineEast Tennessee State UniversityJohnson CityUSA

Personalised recommendations